Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA414 Granules in Acute Ischemic Stroke
CTR20255082Phase 2Terminated
- Sponsor
- Chengdu Diao Jiuhong Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DA414 in ischemic stroke, sponsored by Chengdu Diao Jiuhong Pharmaceutical. Started Dec 2025; status: terminated.
02
Drugs
DA414
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20255082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255082.